Filing Details
- Accession Number:
- 0001127602-17-021019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-09 10:23:09
- Reporting Period:
- 2017-06-08
- Filing Date:
- 2017-06-09
- Accepted Time:
- 2017-06-09 10:23:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Transaction Summary
Sold: | 945 shares | Avg. Price: $95.00 | Total Value: $89,775.00 |
Number of Shares After Transactions: | 13,258 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-08 | 945 | $51.45 | 14,203 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-06-08 | 945 | $95.00 | 13,258 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2017-06-08 | 945 | $0.00 | 945 | $51.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,762 | 2015-05-01 | 2021-05-01 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.